Glypican-3 (GPC3) signaling pathway involved in breast cancer progression

被引：0
|
作者：
Fernandez, Dolores [1 ]
Cercato, Magali [1 ]
Guereno, Macarena [1 ]
Peters, Maria G. [1 ]
机构：
[1] Angel H Roffo Inst Oncol, Buenos Aires, DF, Argentina
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4508
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4508
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Artificial intelligence (AI)-powered quantification of glypican-3 (GPC3) expression facilitates patient selection for GPC3-targeted therapy in solid tumors
    Meng, Ellen
    Meng, Robin
    Tong, Ying
    Li, Yuchen
    Wang, Hong
    Fiorentini, Paola
    Attieh, Elham
    Tang, Qi
    Kefsi, Asma
    Masciari, Serena
    Abbadessa, Giovanni
    Combeau, Cecile
    Tang, Lei
    Pasquier, Benoit
    Wang, Rui
    CANCER RESEARCH, 2024, 84 (06)
  • [32] Glypican-3 expression is silenced in human breast cancer
    Yun-Yan Xiang
    Virginia Ladeda
    Jorge Filmus
    Oncogene, 2001, 20 : 7408 - 7412
  • [33] Glypican-3 expression is silenced in human breast cancer
    Xiang, YY
    Ladeda, V
    Filmus, J
    ONCOGENE, 2001, 20 (50) : 7408 - 7412
  • [34] Establishment of high avidity CTL clones induced by HLA-A2 restricted glypican-3 (GPC3) peptide vaccine
    Yoshikawa, Toshiaki
    Suzuki, Shiro
    Nakatsugawa, Munehide
    Shirakawa, Hirofumi
    Nobuoka, Daisuke
    Sakemura, Noriko
    Motomura, Yutaka
    Nakatsura, Tetsuya
    CANCER RESEARCH, 2011, 71
  • [35] Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma (vol 40, pg 477, 2010)
    Yasuda, E.
    Kumada, T.
    Toyoda, H.
    Kaneoka, Y.
    Maeda, A.
    Okuda, S.
    Yoshimi, N.
    Kozawa, O.
    HEPATOLOGY RESEARCH, 2011, 41 (01) : 101 - 101
  • [36] Growth-suppressing function of glypican-3 (GPC3) via insulin like growth factor II (IGF-II) signaling pathway in ovarian clear cell carcinoma cells
    Sakurai, Maiko
    Shibata, Kiyosumi
    Umezu, Tomokazu
    Kajiyama, Hiroaki
    Yamamoto, Eiko
    Ino, Kazuhiko
    Nawa, Akihiro
    Kikkawa, Fumitaka
    GYNECOLOGIC ONCOLOGY, 2010, 119 (02) : 332 - 336
  • [37] Role of Akt1 on the viability, migration and cytoskeleton organization of murine mammary tumor cells reexpresing glypican-3 (GPC3)
    Romero, Silvina A.
    Lago Huvelle, Maria A.
    Peluffo, Guillermo
    de Kier Joffe, Elisa Bal
    Giselle Peters, Maria
    CANCER RESEARCH, 2011, 71
  • [38] Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors
    Chahoud, Jad
    Zhang, Miao
    Pisters, Louis L.
    Lin, Song-Chang
    Lin, Sue-Hwa
    Tu, Shi-Ming
    CLINICAL GENITOURINARY CANCER, 2018, 16 (05) : 325 - 327
  • [39] Breast cancer: Relationship between GPC3 and EMT process
    Castillo, Lilian F.
    Novack, Gisela V.
    Joffe, Elisa Bal de Kier
    Peters, Maria G.
    CANCER RESEARCH, 2017, 77
  • [40] Glypican-1,-3,-5 (GPC1, GPC3, GPC5) and Hedgehog Pathway Expression in Oral Squamous Cell Carcinoma
    Schlaepfer Sales, Caroline B.
    Guimaraes, Vanessa S. N.
    Valverde, Ludmila F.
    Dias, Rosane B.
    Freitas, Raiza D.
    Siquara da Rocha, Leonardo de Oliveira
    de Miranda, Malu Coelho
    Boas, Deise S. Vilas
    Goncalves Agra, Ivan M.
    dos Santos, Jean N.
    Gurgel Rocha, Clarissa A.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (05) : 345 - 351
12345